Ratios Uncovered: Breaking Down Lyell Immunopharma Inc (LYEL)’s Trailing Twelve Months Metrics

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

The price of Lyell Immunopharma Inc (NASDAQ: LYEL) closed at $0.68 in the last session, down -2.85% from day before closing price of $0.70. In other words, the price has decreased by -$2.85 from its previous closing price. On the day, 0.88 million shares were traded. LYEL stock price reached its highest trading level at $0.7169 during the session, while it also had its lowest trading level at $0.6707.

Ratios:

We take a closer look at LYEL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.43 and its Current Ratio is at 13.43. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on October 30, 2024, Downgraded its rating to Underperform and sets its target price to $1 from $6 previously.

On June 27, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $1.

JP Morgan Downgraded its Overweight to Neutral on August 28, 2023, whereas the target price for the stock was revised from $15 to $5.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYEL now has a Market Capitalization of 203899680 and an Enterprise Value of -192660416. For the stock, the TTM Price-to-Sale (P/S) ratio is 3572.20 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at -3058.102 whereas that against EBITDA is 0.98.

Stock Price History:

The Beta on a monthly basis for LYEL is -0.35, which has changed by -0.6628019 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, LYEL has reached a high of $3.26, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -25.56%, while the 200-Day Moving Average is calculated to be -57.83%.

Shares Statistics:

According to the various share statistics, LYEL traded on average about 1.46M shares per day over the past 3-months and 1180100 shares per day over the past 10 days. A total of 256.56M shares are outstanding, with a floating share count of 144.26M. Insiders hold about 50.62% of the company’s shares, while institutions hold 21.60% stake in the company. Shares short for LYEL as of 1734048000 were 10985361 with a Short Ratio of 7.53, compared to 1731628800 on 9604319. Therefore, it implies a Short% of Shares Outstanding of 10985361 and a Short% of Float of 5.07.

Most Popular